DSE:PHARMAID

Pharma Aids Limited announcements

270 Dhaka Stock Exchange announcements for Pharma Aids Limited (PHARMAID) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2010 (18).

  1. Mr. M. A. Masud, one of the Sponsors/Directors of the company, has reported his intention to sell 700 shares out of his

    Mr. M. A. Masud, one of the Sponsors/Directors of the company, has reported his intention to sell 700 shares out of his total holdings of 2,400 shares of the company at prevailing market price through Stock Exchange within next 30 working days.

  2. Mr. M. A. Masud, one of the Sponsors/Directors of the company, has reported his intention to sell 1,000 shares out of hi

    Mr. M. A. Masud, one of the Sponsors/Directors of the company, has reported his intention to sell 1,000 shares out of his total holdings of 3,400 shares of the company at prevailing market price through Stock Exchange within next 30 working days.

  3. In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Com

    In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

  4. Referring to SEC's directive dated 30.11.10 regarding trade resumption of Pharma Aids Ltd. on 05.12.10 in the spot marke

    Referring to SEC's directive dated 30.11.10 regarding trade resumption of Pharma Aids Ltd. on 05.12.10 in the spot market, we would like to inform all concerned that trading of the shares of the company will resume with new adjusted open price (ex-dividend).

  5. (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2010 (July'10 to Sep'10), the com

    (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2010 (July'10 to Sep'10), the company has reported net profit after tax of Tk. 2.00 million with basic EPS of Tk. 38.49 as against Tk. 1.80 million and Tk. 34.65 respectively for the same period of the previous year. However, considering proposed bonus share @ 500% for the year 2009-10, restated EPS will be Tk. 6.42 as on 30.09.10 and Tk. 5.78 as on 30.09.09.

  6. SEC NEWS: SEC has formed an enquiry committee to investigate in to certain unusual trading in shares of Pharma Aids Limi

    SEC NEWS: SEC has formed an enquiry committee to investigate in to certain unusual trading in shares of Pharma Aids Limited regarding corporate declaration in the Dhaka Stock Exchange Ltd.

  7. As advised by SEC, trading of shares of Pharma Aids Ltd. has been suspended until further instruction.

    As advised by SEC, trading of shares of Pharma Aids Ltd. has been suspended until further instruction.

  8. There will be no price limit on the trading of the shares of the company on 31.10.10 following its corporate declaration

    There will be no price limit on the trading of the shares of the company on 31.10.10 following its corporate declaration.

  9. The Board of Directors has recommended cash dividend @ 30% and stock dividend @ 500% (i.e. 5 bonus shares against 1 ordi

    The Board of Directors has recommended cash dividend @ 30% and stock dividend @ 500% (i.e. 5 bonus shares against 1 ordinary share) for the year ended on June 30, 2010. Date of AGM: 23.12.10, Time: 11:00 AM, Venue: Kandrio Kanchi Kanchar Mela Auditorium, 37/A, Segun Bagicha, Dhaka-1000. Record date: 22.11.10. The company has also reported EPS of Tk. 96.03, NAV per share of Tk. 1,283.13 and Net Operating Cash Flow per share of Tk. 157.85 for the year ended on June 30, 2010.

  10. In response to a DSE query dated 20.10.10, the company has informed that there is no undisclosed price sensitive informa

    In response to a DSE query dated 20.10.10, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.

  11. In response to a DSE query dated 21.09.10, the company has informed that there is no undisclosed price sensitive informa

    In response to a DSE query dated 21.09.10, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.

  12. SEC has issued show-cause cum hearing notice to the company, its Directors, Managing Director and Company Secretary for

    SEC has issued show-cause cum hearing notice to the company, its Directors, Managing Director and Company Secretary for non-compliance of securities related laws in connection with the matter of non-submission of the Capital and Shareholding Position for the month of February 2010, March 2010 and April 2010.

  13. As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2010 (Jan'10 to Mar'10), the company has re

    As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2010 (Jan'10 to Mar'10), the company has reported net profit after tax of Tk. 0.53 million with EPS of Tk. 10.10 as against Tk. 3.04 million and Tk. 58.44 respectively for the same period of the previous year. Whereas net profit was Tk. 4.23 million with EPS of Tk. 81.42 for the period of nine months (July'09 to March'10) ended on 31.03.10 as against Tk. 8.93 million and Tk. 171.73 respectively for the same period of the previous year.

  14. As per un-audited half yearly accounts as on 31.12.09, the Company has reported profit after tax of Tk. 3.71 m. with EPS

    As per un-audited half yearly accounts as on 31.12.09, the Company has reported profit after tax of Tk. 3.71 m. with EPS of Tk. 71.33 as against last year's half yearly of Tk. 5.89 m. and Tk. 113.29 respectively.

  15. Trading of the shares of the company will resume in demat form on 28.01.10 as announced earlier.

    Trading of the shares of the company will resume in demat form on 28.01.10 as announced earlier.

  16. Trading of the shares of the company will remain suspended during January 25-27, 2010 for finalization of Demat process.

    Trading of the shares of the company will remain suspended during January 25-27, 2010 for finalization of Demat process. Trading of the shares of the company will be held in Demat form with effect from January 28, 2010 as announced earlier.

  17. Trading of the shares of the company will be allowed only in the spot market (Block/Odd lot transactions will also be se

    Trading of the shares of the company will be allowed only in the spot market (Block/Odd lot transactions will also be settled as per spot settlement cycle) on January 24, 2010 and trading of the shares of the company will remain suspended during January 25-27, 2010 for finalization of Demat process.

  18. As per decision of SEC, trading of the shares of the company will be held in Demat form with effect from January 28, 201

    As per decision of SEC, trading of the shares of the company will be held in Demat form with effect from January 28, 2010. In this respect, trading of the shares of the company will be allowed only in the spot market on January 24, 2010 and trading of the shares will remain suspended during January 25-27, 2010 for finalization of Demat process.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.